| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cellular Biology |
From the Department of Pharmacology and Toxicology (B.G., J.-S.R., R.B., C.B., H.A.), University of Lausanne, Switzerland; Service of Cardiology (H.A.), CHUV, Lausanne, Switzerland; Department for Cardiovascular Surgery (P.R.), CHUV, Lausanne, Switzerland; Institute of Pathology (H.-A.L.), CHUV, Lausanne, Switzerland; Deparment of Medicine (A.A.D., T.P.), CHUV, Lausanne, Switzerland.
Correspondence to H. Abriel, MD, PhD, SNF-Professor, Department of Pharmacology and Toxicology, Service of Cardiology, University of Lausanne, Bugnon, 27, 1005 Lausanne, Switzerland. E-mail Hugues.Abriel{at}unil.ch
The cardiac sodium channel Nav1.5 plays a key role in cardiac excitability and conduction. The purpose of this study was to elucidate the role of the PDZ domain-binding motif formed by the last three residues (Ser-Ile-Val) of the Nav1.5 C-terminus. Pull-down experiments were performed using Nav1.5 C-terminus fusion proteins and human or mouse heart protein extracts, combined with mass spectrometry analysis. These experiments revealed that the C-terminus associates with dystrophin, and that this interaction was mediated by alpha- and beta-syntrophin proteins. Truncation of the PDZ domain-binding motif abolished the interaction. We used dystrophin-deficient mdx5cv mice to study the role of this protein complex in Nav1.5 function. Western blot experiments revealed a 50% decrease in the Nav1.5 protein levels in mdx5cv hearts, whereas Nav1.5 mRNA levels were unchanged. Patch-clamp experiments showed a 29% decrease of sodium current in isolated mdx5cv cardiomyocytes. Finally, ECG measurements of the mdx5cv mice exhibited a 19% reduction in the P wave amplitude, and an 18% increase of the QRS complex duration, compared with controls. These results indicate that the dystrophin protein complex is required for the proper expression and function of Nav1.5. In the absence of dystrophin, decreased sodium current may explain the alterations in cardiac conduction observed in patients with dystrophinopathies.
Key Words: Duchenne dystrophy dystrophin ECG mouse sodium channels syntrophin
This article has been cited by other articles:
![]() |
C. R. Valdivia, K. Ueda, M. J. Ackerman, and J. C. Makielski GPD1L links redox state to cardiac excitability by PKC-dependent phosphorylation of the sodium channel SCN5A Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1446 - H1452. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Wu, T. Ai, J. J. Kim, B. Mohapatra, Y. Xi, Z. Li, S. Abbasi, E. Purevjav, K. Samani, M. J Ackerman, et al. {alpha}-1-Syntrophin Mutation and the Long-QT Syndrome: A Disease of Sodium Channel Disruption Circ Arrhythm Electrophysiol, August 1, 2008; 1(3): 193 - 201. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hirn, G. Shapovalov, O. Petermann, E. Roulet, and U. T. Ruegg Nav1.4 Deregulation in Dystrophic Skeletal Muscle Leads to Na+ Overload and Enhanced Cell Death J. Gen. Physiol., July 28, 2008; 132(2): 199 - 208. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ueda, C. Valdivia, A. Medeiros-Domingo, D. J. Tester, M. Vatta, G. Farrugia, M. J. Ackerman, and J. C. Makielski Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complex PNAS, July 8, 2008; 105(27): 9355 - 9360. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mazzone, P. R. Strege, D. J. Tester, C. E. Bernard, G. Faulkner, R. De Giorgio, J. C. Makielski, V. Stanghellini, S. J. Gibbons, M. J. Ackerman, et al. A Mutation in Telethonin Alters Nav1.5 Function J. Biol. Chem., June 13, 2008; 283(24): 16537 - 16544. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Bezzina and C. A. Remme Dilated Cardiomyopathy due to Sodium Channel Dysfunction: What Is the Connection? Circ Arrhythm Electrophysiol, June 1, 2008; 1(2): 80 - 82. [Full Text] [PDF] |
||||
![]() |
J. Ge, A. Sun, V. Paajanen, S. Wang, C. Su, Z. Yang, Y. Li, S. Wang, J. Jia, K. Wang, et al. Molecular and Clinical Characterization of a Novel SCN5A Mutation Associated With Atrioventricular Block and Dilated Cardiomyopathy Circ Arrhythm Electrophysiol, June 1, 2008; 1(2): 83 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Urasawa, M. R. Wada, N. Machida, K. Yuasa, Y. Shimatsu, Y. Wakao, S. Yuasa, T. Sano, I. Nonaka, A. Nakamura, et al. Selective Vacuolar Degeneration in Dystrophin-Deficient Canine Purkinje Fibers Despite Preservation of Dystrophin-Associated Proteins With Overexpression of Dp71 Circulation, May 13, 2008; 117(19): 2437 - 2448. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wu, S. L. Yong, C. Fan, Y. Ni, S. Yoo, T. Zhang, X. Zhang, C. A. Obejero-Paz, H.-J. Rho, T. Ke, et al. Identification of a New Co-factor, MOG1, Required for the Full Function of Cardiac Sodium Channel Nav1.5 J. Biol. Chem., March 14, 2008; 283(11): 6968 - 6978. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Petitprez and H. Abriel Effects of heart failure on brain-type Na+ channels in rabbit ventricular myocytes Europace, February 1, 2008; 10(2): 257 - 257. [Full Text] [PDF] |
||||
![]() |
S. E. Lehnart, M. J. Ackerman, D. W. Benson Jr, R. Brugada, C. E. Clancy, J. K. Donahue, A. L. George Jr, A. O. Grant, S. C. Groft, C. T. January, et al. Inherited Arrhythmias: A National Heart, Lung, and Blood Institute and Office of Rare Diseases Workshop Consensus Report About the Diagnosis, Phenotyping, Molecular Mechanisms, and Therapeutic Approaches for Primary Cardiomyopathies of Gene Mutations Affecting Ion Channel Function Circulation, November 13, 2007; 116(20): 2325 - 2345. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Schulze-Bahr Cardiac sodium channels: Dysregulation meets myocardial failure Cardiovasc Res, August 1, 2007; 75(3): 455 - 456. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |